194 related articles for article (PubMed ID: 30587963)
1. Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.
Jiang GY; Li Q; Lv YX
Int J Chron Obstruct Pulmon Dis; 2019; 14():73-80. PubMed ID: 30587963
[TBL] [Abstract][Full Text] [Related]
2. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
Wang Y; Yang Y; Chen P; Luo Y; Yang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
[TBL] [Abstract][Full Text] [Related]
3. The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure.
Guo X; Nie H; Chen Q; Chen S; Deng N; Li R; Ding X; Hu S; Wang A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2931-2940. PubMed ID: 30275691
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
[TBL] [Abstract][Full Text] [Related]
5. Intravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary disease.
Zhang J; Zhao G; Yu X; Pan X
Respirology; 2012 May; 17(4):715-20. PubMed ID: 22394412
[TBL] [Abstract][Full Text] [Related]
6. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
[TBL] [Abstract][Full Text] [Related]
7. NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
Tian F; Song W; Wang L; Zeng Q; Zhao Z; Feng N; Fan J; Wang Y; Wang J; Ma X
Respir Res; 2021 Dec; 22(1):321. PubMed ID: 34961527
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
[TBL] [Abstract][Full Text] [Related]
10. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
[TBL] [Abstract][Full Text] [Related]
11. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
[TBL] [Abstract][Full Text] [Related]
12. Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study.
Ozdemirel TS; Ulaşli SS; Yetiş B; Karaçağlar E; Bayraktar N; Ulubay G
Anadolu Kardiyol Derg; 2014 Jun; 14(4):370-7. PubMed ID: 24818627
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between N-terminal probrainnatriuretic peptide and prognosis of acute exacerbations of chronic obstructive pulmonary disease].
Zhao CL; Zhang QR; Huang JW; Zhang L; Zhou M
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):95-99. PubMed ID: 29429214
[No Abstract] [Full Text] [Related]
15. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.
Høiseth AD; Omland T; Hagve TA; Brekke PH; Søyseth V
Respir Res; 2012 Oct; 13(1):97. PubMed ID: 23107284
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.
Chen YR; Chen V; Hollander Z; Leipsic JA; Hague CJ; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
PLoS One; 2017; 12(3):e0174063. PubMed ID: 28328968
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
Nishimura K; Nishimura T; Onishi K; Oga T; Hasegawa Y; Jones PW
Int J Chron Obstruct Pulmon Dis; 2014; 9():155-62. PubMed ID: 24523584
[TBL] [Abstract][Full Text] [Related]
19. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
